Healio

Enzyme replacement therapy curbs bleeding events in congenital blood clotting disorder

Please provide your email address to receive an email when new articles are posted on . Mean maximum ADAMTS13 activity after recombinant ADAMTS13 exceeded 100%. Markedly fewer patients receiving ...
FiercePharma

Takeda scores second FDA approval this week with green light for rare blood clotting disorder drug Adzynma

Thanks to a Takeda approval Thursday, patients now have a drug to tackle a rare inherited blood clotting disorder. The U.S. FDA has given a green light to Takeda’s Adzynma, the first recombinant ...
Yahoo

Takeda Pharma gets US FDA approval for rare blood disorder therapy

(Reuters) -The U.S. Food and Drug Administration on Thursday approved Takeda Pharmaceutical's therapy to treat a rare genetic blood disorder in adult and pediatric patients. Takeda's Adzynma becomes ...
WWLTV

FDA approves first treatment for rare blood disorder in pediatric patients 12 and older

WASHINGTON — The Food and Drug Administration has approved the first drug treatment for pediatric patients 12 and older with a rare blood disorder. The treatment for acquired thrombotic ...
Verywell Health on MSN

Types and causes of blood clotting disorders

Blood clotting disorders can be inherited or acquired and lead to either excessive bleeding or too much clotting.